Literature DB >> 20715737

The effect of remifentanil on the incidence of agitation on emergence from sevoflurane anaesthesia in children undergoing adenotonsillectomy.

Y X Dong1, L X Meng, Y Wang, J J Zhang, G Y Zhao, C H Ma.   

Abstract

The aim of the present study was to assess the effect of remifentanil on the incidence of emergence agitation in preschool-aged children undergoing adenotonsillectomy with sevoflurane anaesthesia. Sixty children, aged three to seven years, American Society of Anesthesiologists physical status I or II, were randomised into either group S (sevoflurane alone, n=30) or group R (sevoflurane plus remifentanil, n=30). Anaesthesia was induced with an intravenous bolus injection of fentanyl 3 microg/kg and propofol 2.5 mg/kg. Endotracheal intubation was facilitated by vecuronium 0.1 mg/kg. All patients were ventilated with 50% nitrous oxide and 1.5 to 2.5% sevoflurane in oxygen. End-tidal CO2 was maintained at 35 +/- 4 mmHg. Group S received no other medication while group R received remifentanil 1 microg/kg/minute intraoperatively. Mean blood pressure, heart rate, pulse oximetry, eye-opening time and extubation time were recorded in the operating room. In recovery, emergence agitation was assessed using the Pediatric Anesthesia Emergence Delirium scale with a score > or =10 taken as indicating agitation. Emergence agitation occurred in 20 of the 30 patients in group S and seven of the 30 patients in group R (P < 0.01). In preschool-aged children undergoing adenotonsillectomy with sevoflurane general anaesthesia, after propofol and fentanyl induction, intraoperative remifentanil decreased the incidence of emergence agitation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20715737     DOI: 10.1177/0310057X1003800416

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  8 in total

Review 1.  Emergence Delirium in Pediatric Anesthesia.

Authors:  Arthura D Moore; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2017-02       Impact factor: 3.022

2.  Preventing Emergence Agitation Using Ancillary Drugs with Sevoflurane for Pediatric Anesthesia: A Network Meta-Analysis.

Authors:  Xin Wang; Qi Deng; Bin Liu; Xiangdi Yu
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

3.  The Effects of Remifentanil and Fentanyl on Emergence Agitation in Pediatric Strabismus Surgery.

Authors:  Jongyoon Baek; Sang Jin Park; Jun Oh Kim; Minhyun Kim; Do Young Kim; Eun Kyung Choi
Journal:  Children (Basel)       Date:  2022-04-24

4.  Comparison between dexmedetomidine and remifentanil infusion in emergence agitation during recovery after nasal surgery: A randomized double-blind trial.

Authors:  R Polat; K Peker; I Baran; G Bumin Aydın; Ç Topçu Gülöksüz; A Dönmez
Journal:  Anaesthesist       Date:  2015-09-02       Impact factor: 1.041

5.  Comparison of emergence time in children undergoing minor surgery according to anesthetic: desflurane and sevoflurane.

Authors:  Jeong Min Kim; Jae Hoon Lee; Hye Jin Lee; Bon-Nyeo Koo
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

6.  Effects of remifentanil and remifentanil-alfentanil administration on emergence agitation after brief ophthalmic surgery in children.

Authors:  Yi Hwa Choi; Kyung Mi Kim; Soo Kyung Lee; Yi Seul Kim; Seon Ju Kim; Woon Suk Hwang; Jin Huan Chung
Journal:  BMC Anesthesiol       Date:  2016-08-02       Impact factor: 2.217

7.  Optimal Dexmedetomidine Dose to Prevent Emergence Agitation Under Sevoflurane and Remifentanil Anesthesia During Pediatric Tonsillectomy and Adenoidectomy.

Authors:  Yan-Zhuo Zhang; Xue Wang; Jia-Min Wu; Chun-Yu Song; Xiao-Guang Cui
Journal:  Front Pharmacol       Date:  2019-09-19       Impact factor: 5.810

8.  Dexmedetomidine Injection during Strabismus Surgery Reduces Emergence Agitation without Increasing the Oculocardiac Reflex in Children: A Randomized Controlled Trial.

Authors:  In-Ae Song; Kwang-Suk Seo; Ah-Young Oh; Ji-Seok Baik; Jin Hee Kim; Jung-Won Hwang; Young-Tae Jeon
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.